CI
HZNP

Cowen Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cowen Inc’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$10K Buy
+20,000
New +$507K ﹤0.01% 408
2016
Q1 		– Sell
-33,400
Closed -$724K – 380
2015
Q4 		$724K Hold
33,400
– – 0.05% 167
2015
Q3 		$662K Buy
+33,400
New +$1.06M 0.04% 163

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cowen Inc's HZNP Position: Q2 2019 in Review

Cowen Inc opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2019: 6,000 shares worth $144K. The stake represents 0.01% of the portfolio and ranks #275 among its holdings. This is a return to the name: Cowen Inc previously reported a position in HZNP as recently as Q4 2017.

Cowen Inc first reported a position in HZNP in Q1 2014 and has held it in 11 quarters since. The position peaked at $5.02M in Q4 2014. 272 funds tracked by Wall St. Rank hold HZNP as of Q2 2019.

  • Cowen Inc held 6,000 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $144K as of Q2 2019.
  • Horizon Therapeutics Public Limited Company Ordinary Shares was a new Cowen Inc position in Q2 2019.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.01% of Cowen Inc's portfolio in Q2 2019, its #275 holding.
  • Cowen Inc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and has held it in 11 quarters since.
  • Cowen Inc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.02M in Q4 2014.
  • 272 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.